Benign prostate hyperplasia (BPH) was linked with metabolic syndrome in a large cohort of men from the UK, researchers found. “To our knowledge, this is the largest study to examine the prevalence of metabolic syndrome in a representative sample of men in the UK with and without BPH”.
The diets of many cancer survivors do not meet 2010 dietary guidelines set by the US Department of Agriculture, and many many survivors eat poorer-quality diets, more empty calories, and less fiber than the general population.
A new study suggests that diverticulitis became more common in the U.S. from the late 1990s to the mid-2000s.
One year of high-dose vitamin D treatment results in no clinically meaningful benefit for postmenopausal women with vitamin D insufficiency, according to a randomized controlled clinical trial published in the October issue of JAMA Internal Medicine.
Suicide attempts increase substantially in morbidly obese patients in the years following bariatric surgery, when the “honeymoon” period of substantial weight loss comes to an end, new research shows.
As add-on therapy to metformin in type 2 diabetes, dipeptidyl peptidase-4 (DPP4) inhibitors are associated with fewer adverse outcomes than sulfonylureas, researchers from Taiwan report.
Drug-induced bullous pemphigoid (BP) has been recently reported in association with sitagliptin and vildagliptin, 2 dipeptidyl peptidase-4 (DPP-4) inhibitors used in the treatment of type 2 diabetes mellitus (T2DM). Herein, we report the development of BP in 2 patients with T2DM treated with linagliptin, another DPP-4 inhibitor.
On July 25, the US Food and Drug Administration (FDA) approved alirocumab (Praluent), the first in a new class, the proprotein convertase subtilisin/kexin type 9 (PCSK-9) inhibitors. Approval of a second medication in the class is expected shortly.
Patient outcomes depend just as much on well-coordinated teams as they do on technically skilled clinicians, said Atul Gawande, MD, a health policy professor at the Harvard T.H. Chan School of Public Health in Boston and a staff writer at The New Yorker.
Analysis of the microbiome surrounding colon cancer tumors could be used as a noninvasive screening test that is more sensitive and specific than fecal occult blood testing, according to the results of a new study.
The World Health Organization’s Fracture Risk Assessment Tool (FRAX) underestimates the 10-year fracture risk for people with mental illness—notably depression—and those taking drugs for psychiatric conditions—notably selective serotonin reuptake inhibitors (SSRIs), mood stabilizers (lithium, anticonvulsants, atypical antipsychotics), other antipsychotics, or benzodiazepines, claims new research.